Introduction Blood transfusions are life-saving medical procedures, but incompatible blood types can lead to severe and potentially fatal reactions. To ensure safety, we rely on a meticulous process of antibody identification, and a key tool in this process is the...
TL;DR Non-Hodgkin lymphoma (disease) is a cancer of the lymphatic system, which is part of the immune system. It arises from lymphocytes (white blood cells) that become abnormal and grow uncontrollably. Classification ▾ Non-Hodgkin lymphoma (disease) is classified...
Introduction A key component of pre-transfusion testing is antibody identification (ABID). This procedure identifies clinically significant antibodies present in the recipient’s plasma or serum that can react with antigens on donor red blood cells (RBCs). These...
Introduction Antibody screening, a cornerstone of blood transfusion safety, aims to detect clinically significant unexpected red blood cell (RBC) antibodies in a patient’s plasma or serum. These antibodies can develop through various mechanisms, including...
Recent Comments